Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alliance Pharma Plc (APH.LN)

Alliance Pharma Plc (APH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alliance Pharma Plc Bath Road Avonbridge House Chippenham Wiltshire SN15 2BB GBR

https://www.alliancepharmaceuticals.com P: 124-946-6966 F: 124-946-6977

Description:

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Key Statistics

Overview:

Market Capitalization, $K 183,736
Shares Outstanding, K 540,400
Annual Sales, $ 167,416 K
Annual Net Income, $ 936 K
% of Insider Shareholders 10.32%
% of Institutional Shareholders 46.07%

Growth:

1-Year Return -49.40%
3-Year Return -65.01%
5-Year Return -58.08%
5-Year Revenue Growth 10.50%
5-Year Earnings Growth -51.00%
5-Year Dividend Growth 6.59%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year -0.87%
Annual Dividend Rate, $ 0.02
Most Recent Dividend 0.012 on 06/22/23
Next Ex-Dividends Date 06/22/23
Dividend Payable Date 07/18/23
Dividend Payout Ratio 0.00%

APH.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 7.63
Return-on-Equity % -2.46%
Return-on-Assets % -1.33%
Profit Margin % 0.56%
Debt/Equity 0.48
Price/Sales 1.08
Price/Book 0.66
Book Value/Share 0.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar